TSHA Institutional Ownership & Shareholders

TAYSHA GENE THERAPIES INC (TSHA) is currently held by 205 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $2.04B based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

Avoro Capital Advisors Llc is currently the largest disclosed institutional shareholder of TSHA tracked by InsiderSet, reporting ownership valued at approximately $162.68M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $98.66M, representing an estimated loss of -39.35% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 59% of the total disclosed TSHA value among the investors covered in this analysis. Major shareholders include Avoro Capital Advisors Llc, Ra Capital Management, L.P., Goldman Sachs Group Inc, and several other long-term asset managers with concentrated positions in TAYSHA GENE THERAPIES INC (TSHA).

This page ranks the largest institutional TSHA shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

205

Total Reported Value

$2.04B

Largest Holder

Avoro Capital Advisors Llc

Largest Position

$162.68M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

64

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Avoro Capital Advisors Llc1.46%23,888,888$162,683,327$98,661,107-$64,022,220-39.35%
Ra Capital Management, L.P.1.39%23,555,648$160,413,963$97,284,826-$63,129,137-39.35%
Goldman Sachs Group Inc0.02%22,713,118$154,676,334$93,805,177-$60,871,157-39.35%
Blackrock, Inc.0.00%20,691,927$140,912,023$85,457,659-$55,454,364-39.35%
Vestal Point Capital, Lp3.09%19,415,000$132,216,150$80,183,950-$52,032,200-39.35%
Morgan Stanley0.01%16,487,479$112,279,731$68,093,288-$44,186,443-39.35%
Rtw Investments, Lp0.79%13,560,258$92,345,357$56,003,866-$36,341,491-39.35%
Fmr Llc0.00%13,336,413$90,820,969$55,079,386-$35,741,583-39.35%
Vanguard Capital Management Llc0.00%12,478,595$84,979,232$51,536,597-$33,442,635-39.35%
State Street Corp0.00%11,421,920$77,783,275$47,172,530-$30,610,745-39.35%
Siren, L.L.C.1.36%9,846,579$67,055,203$40,666,371-$26,388,832-39.35%
Octagon Capital Advisors Lp6.06%9,693,244$66,010,992$40,033,098-$25,977,894-39.35%
Geode Capital Management, Llc0.00%6,560,394$44,685,322$27,094,427-$17,590,895-39.37%
Polar Capital Holdings Plc0.10%5,117,133$34,847,676$21,133,759-$13,713,917-39.35%
Mpm Bioimpact Llc1.87%4,500,000$30,645,000$18,585,000-$12,060,000-39.35%
D. E. Shaw & Co., Inc.0.02%4,398,652$29,954,821$18,166,433-$11,788,388-39.35%
Baker Bros. Advisors Lp0.14%4,004,756$27,272,388$16,539,642-$10,732,746-39.35%
Wellington Management Group Llp0.00%3,975,605$27,073,870$16,419,249-$10,654,621-39.35%
Healthcare Of Ontario Pension Plan Trust Fund0.04%3,885,501$26,460,262$16,047,119-$10,413,143-39.35%
Gordonmd Global Investments Lp11.86%723,185$24,501,508$2,986,754-$21,514,754-87.81%
Casdin Capital, Llc1.11%3,250,000$22,132,500$13,422,500-$8,710,000-39.35%
Vanguard Portfolio Management Llc0.00%3,140,009$21,383,461$12,968,237-$8,415,224-39.35%
Adar1 Capital Management, Llc0.97%3,040,466$20,705,573$12,557,125-$8,148,448-39.35%
Pictet Asset Management Holding Sa0.02%2,770,701$18,868,474$11,442,995-$7,425,479-39.35%
Aberdeen Group Plc0.02%2,327,152$15,847,905$9,611,138-$6,236,767-39.35%
Norges Bank0.00%2,233,600$15,210,816$9,224,768-$5,986,048-39.35%
Northern Trust Corp0.00%2,226,210$15,160,491$9,194,247-$5,966,244-39.35%
Charles Schwab Investment Management Inc0.00%2,200,695$14,986,733$9,088,870-$5,897,863-39.35%
Millennium Management Llc0.01%2,126,838$14,483,767$8,783,841-$5,699,926-39.35%
Orbimed Advisors Llc0.26%2,000,000$13,620,000$8,260,000-$5,360,000-39.35%
Rice Hall James & Associates, Llc0.66%1,992,229$13,567,079$8,227,906-$5,339,173-39.35%
Vanguard Fiduciary Trust Co0.00%1,896,474$12,914,988$7,832,438-$5,082,550-39.35%
B Group, Inc.6.96%1,800,556$12,261,786$7,436,296-$4,825,490-39.35%
Affinity Asset Advisors, Llc0.58%1,750,000$11,917,500$7,227,500-$4,690,000-39.35%
Barclays Plc0.00%1,630,659$11,104,787$6,734,622-$4,370,165-39.35%
Citadel Advisors Llc0.01%1,535,287$10,455,305$6,340,735-$4,114,570-39.35%
Heights Capital Management, Inc2.36%1,500,000$10,215,000$6,195,000-$4,020,000-39.35%
Seven Fleet Capital Management Lp1.64%1,504,400$9,940,323$6,213,172-$3,727,151-37.50%
Palo Alto Investors Lp1.31%1,391,382$9,475,311$5,746,408-$3,728,903-39.35%
Bank Of America Corp0.00%1,372,845$9,349,074$5,669,850-$3,679,224-39.35%
Granahan Investment Management, Llc0.32%1,305,177$8,888,255$5,390,381-$3,497,874-39.35%
First Trust Advisors Lp0.00%791,169$5,387,860$3,267,528-$2,120,332-39.35%
Jpmorgan Chase & Co0.00%766,282$5,157,078$3,164,745-$1,992,333-38.63%
Sands Capital Alternatives, Llc0.80%724,873$4,936,385$2,993,725-$1,942,660-39.35%
Bank Of New York Mellon Corp0.00%697,971$4,753,180$2,882,620-$1,870,560-39.35%
Bnp Paribas Financial Markets0.00%640,035$4,358,638$2,643,345-$1,715,293-39.35%
Quantum Private Wealth, Llc1.04%836,071$4,071,665$3,452,973-$618,692-15.20%
Panagora Asset Management Inc0.01%590,387$4,020,535$2,438,298-$1,582,237-39.35%
Ubs Group Ag0.00%588,427$4,007,188$2,430,204-$1,576,984-39.35%
Affinity Wealth Management Llc0.51%576,808$3,928,062$2,382,217-$1,545,845-39.35%
Showing 50 of 204

Frequently asked questions about TSHA

  • Who are the largest institutional holders of TSHA?

    The largest institutional holders of TSHA reported in the latest SEC Form 13F filings include Avoro Capital Advisors Llc, Ra Capital Management, L.P., Goldman Sachs Group Inc, Blackrock, Inc., and Vestal Point Capital, Lp. InsiderSet ranks institutional holders by their latest reported TSHA position.

  • What is TSHA institutional ownership?

    This page tracks TSHA positions reported by institutional investment managers through SEC Form 13F. TAYSHA GENE THERAPIES INC (TSHA) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.

  • How many institutions own TSHA?

    InsiderSet currently tracks 205 institutional managers reporting TSHA holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of TSHA shareholders.

  • How much TSHA stock do institutions own?

    Institutional investment managers disclosed approximately $2.04B in TSHA holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.

  • When was TSHA institutional ownership last updated?

    The latest TSHA institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.

  • Are institutional TSHA holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its TSHA position after the reporting date.

  • Are institutions buying or selling TSHA?

    Institutional buying and selling can be analyzed by comparing TSHA positions across consecutive 13F reporting periods. InsiderSet's TSHA Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View TSHA ownership changes.

  • How has TSHA institutional ownership changed over time?

    InsiderSet tracks TSHA institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.